Activity Provided By:

Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

RME Hot Seat: Weighing the Clinical Evidence on Treatment Strategies for Myeloma

Overview / Abstract:	This RME Hot Seat provides a virtual Q&A with a panel of multiple myeloma (MM) experts who field a range of questions on MM patient care, covering such topics as the use of minimal residual disease (MRD)–driven maintenance approaches, immunotherapy, the use of belantamab mafodotin, cytogenetic risk status, and the value of three-drug and four-drug regimens. Learning Objectives Upon completion of this activity, participants should be better able to: - Evaluate emerging data regarding the approach to maintenance therapy based on MRD status - Describe the options available to patients who have relapsed from or are resistant to multiple prior therapies - Incorporate the use of novel agent/monoclonal antibody–based regimens for newly diagnosed or relapsed/refractory MM patients based on currently available evidence
Expiration	Apr 16, 2022
Discipline(s)	Nurse Practitioner , Physician CME, Physician Assistant CME
Format	Online
Credits / Hours	This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine, RedMedEd, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Penn State College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation	ACCME
Presenters / Authors / Faculty	Hearn Jay Cho, MD, PhD Chief Medical Officer Multiple Myeloma Research Foundation Norwalk, Connecticut Associate Professor of Medicine Icahn School of Medicine at Mount Sinai New York, New York Adam D. Cohen, MD Associate Professor of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania Suzanne Lentzsch, MD, PhD Professor of Medicine College of Physicians and Surgeons Columbia University Medical Center Director, Multiple Myeloma and Amyloidosis Service New York Presbyterian Hospital/Columbia University Medical Center New York, New York
Activity Specialities / Related Topics	Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy
Sponsors / Supporters / Grant Providers	Support for this activity has been provided through educational grants from Adaptive Biotechnologies Corporation; Amgen, Inc.; Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics, Inc.; and Oncopeptides. The joint sponsors also wish to thank CURE and Targeted Oncology for their support.
Keywords / Search Terms	RedMedEd RedMedEd RedMedEd RedMedEd MMRF, MM, multiple myeloma, multiple myeloma research foundation, new strategies, diagnosis, assessing prognosis, monitoring, minimal residual disease, MRD, supportive care, new drugs, management, options, debate, treatment, Free, CME, CE, hematologist, hematology, oncology, clinical data, therapy Free CE CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map